These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6173558)

  • 21. Variability of natural killer activity during immunotherapy.
    Cheknev SB
    Bull Exp Biol Med; 2004 Feb; 137(2):171-4. PubMed ID: 15273767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cells.
    Kimber I
    Med Lab Sci; 1985 Jan; 42(1):60-77. PubMed ID: 2580211
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual mechanism of interferon augmentation of natural killer cytotoxicity (NKCC).
    Targan S; Dorey F
    Ann N Y Acad Sci; 1980; 350():121-9. PubMed ID: 6165267
    [No Abstract]   [Full Text] [Related]  

  • 24. Natural killer cell activity in patients with multiple sclerosis given alpha interferon.
    Rice GP; Casali P; Merigan TC; Oldstone MB
    Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Circulating serum interferon and its effect on human natural killer cell activity].
    Cheknev SB; Ashmanova IaG; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Dec; 118(12):619-22. PubMed ID: 7535580
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical immunological and immunogenetical aspects of neurological diseases.
    Péterfalvi A
    Ideggyogy Sz; 2010 Jan; 63(1-2):52-60. PubMed ID: 20420125
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of immune lysis of tumor cells by interferon.
    Ng AK; Imai K; Pellegrino MA; Vitiello A; Indiveri F; Wilson BS; Ferrone S
    Biomembranes; 1983; 11():313-39. PubMed ID: 6187384
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S; Møller-Larsen A; Pedersen E
    Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regulation of the activity of human natural killer cells by autologous interferon].
    Cheknev SB; Ershov FI; Pritsker AD; Latysheva OL
    Biull Eksp Biol Med; 1994 Sep; 118(9):281-4. PubMed ID: 7819561
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural cytotoxicity in AKR/J mice during adjuvant induced amyloidogenesis.
    Fuhrman SA; Parkinson DR; Waksal SD; McAdam KP
    Cell Immunol; 1982 Jun; 70(1):170-9. PubMed ID: 6180838
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of adherent cells in supporting natural cytotoxicity reactions].
    Sorokin AM; Chenëv SB; Koval'chuk LV
    Biull Eksp Biol Med; 1989 Sep; 108(9):322-5. PubMed ID: 2611391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the relevance of the various immunomodulatory effects of interferons?
    Morris A
    Ann Inst Pasteur Immunol (1985); 1985; 136D(1):79-81. PubMed ID: 2415043
    [No Abstract]   [Full Text] [Related]  

  • 34. NK susceptibility varies inversely with target cell class I HLA antigen expression.
    Storkus WJ; Howell DN; Salter RD; Dawson JR; Cresswell P
    J Immunol; 1987 Mar; 138(6):1657-9. PubMed ID: 3819393
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural killer cell activity in patients with multiple sclerosis: interferon and plasmapheresis.
    Uchida A; Maida EM; Lenzhofer R; Micksche M
    Immunobiology; 1982 Feb; 160(5):392-402. PubMed ID: 6175561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Natural killer cell activity in multiple sclerosis patients].
    Pál E; Varjú G; Vécsei L; Szekeres J; Pálffy G
    Orv Hetil; 1997 Dec; 138(50):3167-70. PubMed ID: 9446081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 38. Human natural killer cells.
    Trinchieri G; Perussia B; Santoli D; Cerottini JC
    Transplant Proc; 1979 Mar; 11(1):807-10. PubMed ID: 452106
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytotoxic effector mechanisms in AIDS.
    Cunningham-Rundles S; Metroka CE; Safai B; Krim M; Rubin BY; Hayward G
    Adv Exp Med Biol; 1985; 187():97-110. PubMed ID: 2412419
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
    Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.